Leodevico L. Ilag
Director/Board Member bei PLENTEX LIMITED
Profil
Leodevico L.
Ilag is the founder of Xerion Pharmaceuticals AG, which was founded in 1998.
He held the title of MD, Chief Scientific & Technology Officer from 1998 to 2004.
Currently, he is a Non-Executive Director at Plentex Ltd.
Dr. Ilag's former positions include Chief Operating Officer at Patrys Ltd.
and Chief Scientific Officer at Manalto Ltd.
Aktive Positionen von Leodevico L. Ilag
| Unternehmen | Position | Beginn |
|---|---|---|
| PLENTEX LIMITED | Director/Board Member | - |
Ehemalige bekannte Positionen von Leodevico L. Ilag
| Unternehmen | Position | Ende |
|---|---|---|
Xerion Pharmaceuticals AG
 Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Xerion Pharmaceuticals GmbH develops antibodies and therapeutic targets. It uniquely focuses on proteins, using proprietary technologies to selectively block their function in diseased cells thereby mimicking the activity of a drug. The company is headquartered in Munich, Germany. | Founder | 01.01.2004 |
| MANALTO LIMITED | Chief Tech/Sci/R&D Officer | - |
| PATRYS LIMITED | Chief Operating Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PATRYS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Plentex Ltd.
 Plentex Ltd. Agricultural Commodities/MillingProcess Industries Plentex Ltd. engages in the provision of agricultural processing and aquaculture business. It markets acquafeed, and staple food crop products such as virgin coconut oil, coconut flour, coconut water, and other valuable by-products as well as milled rice, rice bran and tapioca. The company was founded on May 19, 1983 and is headquartered in Brighton, Australia. | Process Industries |
Manalto Ltd.
 Manalto Ltd. Packaged SoftwareTechnology Services Manalto Ltd. engages in the development and commercialization of social media management software. It operates through the following geographical segments: Australia, USA, Ireland, South Africa, and the Netherlands. The company was founded by Gregory Edward Rice, Nick Gatsios, Anthony Owen and Allan Graham Watman on November 2, 2001 and is headquartered in Annangrove, Australia. | Technology Services |
Xerion Pharmaceuticals AG
Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Xerion Pharmaceuticals GmbH develops antibodies and therapeutic targets. It uniquely focuses on proteins, using proprietary technologies to selectively block their function in diseased cells thereby mimicking the activity of a drug. The company is headquartered in Munich, Germany. | Health Technology |
